Mass Cytometry Animation
CyTOF XT™ is the most technologically advanced mass cytometer to date. It is designed to build on the benefits of mass cytometry technology whilst streamlining operation and automating sample acquisition for the best-timed results and reproducibility from every run.
This mechanism of action (MoA) animation was created to visually convey the science behind Fluidigm’s apparatus, exploring the key features of their CyTOF™ technology and the CyTOF XT™. The animation uses stunning, eye-catching visuals to give the viewer a closer look at the CyTOF XT™ machine.
Stills from the animation can be found throughout the webpage, as well as on the homepage main scroll banner, helping build a clear and strong brand identity.
Are you interested in seeing how our award-winning medical animation can help you?
Random42 constantly strives to innovate in the medical animation space. Get in touch for a consultation on your next project.
‘‘For experts, there’s limited time in which they will interact with this content, so getting a message across quickly is crucial, and this medium does it very well.’’
Product Manager, GSK
‘‘Their turnaround time sets them apart from the rest of the field. The fact they can turnaround lots of comments in a couple of days is impressive, whereas that took weeks with other agencies we worked with. They’re well above the benchmark.’’
Oncology Clinical Liaison, Bristol-Myers Squibb
‘‘It was a combination equally of quality of work but also the comfort and confidence that I knew I would be working with PhDs. They gave me the confidence that they would have the ability to understand. The other companies didn’t have those sorts of people on staff, they were just good animators. That was the area where I felt that I could trust Random42 would deliver.’’
Senior Product Manager, Spectranetics
‘‘I have been to a lot of conferences and I have seen a lot of videos both from competitors and internally – in my eyes it is night and day. The quality Random42 have is not one step ahead, it is far ahead compared to what I have seen before.’’
Product Manager, Amgen